Literatur
- 1
Carson J L, Duff A, Poses R M, Berlin J A, Spence R K, Trout R. et al .
Effect of anaemia and cardiovascular disease on surgical mortality and morbidity.
Lancet.
1996;
348 (9034)
1055-1060
- 2
Carson J L, Duff A, Berlin J A, Lawrence V A, Poses R M, Huber E C. et al .
Perioperative blood transfusion and postoperative mortality.
JAMA.
1998;
279(3)
199-205
- 3
Hebert P C, Wells G, Blajchman M A, Marshall J, Martin C, Pagliarello G. et al .
A multicenter, randomized, controlled clinical trial of transfusion requirements in
critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical
Care Trials Group.
N. Engl. J. Med..
1999;
340(6)
409-417
- 4
Mercuriali F, Intaglietta M.
Proposal of an algorithm to help the choice of the best transfusion strategy.
Curr. Med. Res. Opin..
1996;
13(13)
465-478
- 5
Forgie M A, Wells P S, Laupacis A, Fergusson D.
Preoperative autologous donation decreases allogeneic transfusion but increases exposure
to all red blood cell transfusion: results of a meta-analysis. International Study
of Perioperative Transfusion (ISPOT) Investigators.
Arch Intern. Med..
1998;
158(6)
610-616
- 6
Monk T G, Goodnough L T, Birkmeyer J D, Brecher M E, Catalona W J.
Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous
blood donation by patients undergoing radical retropubic prostatectomy.
Transfusion.
1995;
35
559-565
- 7
Monk T G, Goodnough L T, Brecher M E, Pulley D D, Colberg J W, Andriole G L. et al
.
Acute normovolemic hemodilution can replace preoperative autologous blood donation
as a standard of care for autologous blood procurement in radical prostatectomy.
Anesth. Analg..
1997;
85(5)
953-958
- 8
Monk T G, Goodnough L T, Brecher M E, Colberg J W, Andriole G L, Catalona W J.
A prospective randomized comparison of three blood conservation strategies for radical
prostatectomy.
Anesthesiology.
1999;
91(1)
24-33
- 9
Ness P M, Bourke D L, Walsh P C.
A randomized trial of perioperative hemodilution versus transfusion of preoperatively
deposited autologous blood in elective surgery.
Transfusion.
1992;
32
226-230
- 10
Stubenvoll E, Gries M, Gombotz H, Szipurzynski S, Ehall R.
Comparison of EPO-supported haemodilution with predonation of autologous blood for
total hip replacement.
Br. J. Anaesth..
1997;
78
65
- 11
Monk T G, Goodnough L T, Brecher M E, Colberg J W, Andriole G L, Catalona W J.
A prospective randomized comparison of three blood conservation strategies for radical
prostatectomy.
Anesthesiology.
1999;
91(1)
24-33
- 12 Gombotz H, Gries M, Sipurzynski S, Fruhwald S, Rehak P. Preoperative treatment
with recombinant human erythropoietin or predeposit of autologous blood in women undergoing
primary hip replacement. Acta Anaesthesiol. Scand. 2000, im Druck
- 13
Brcher M E, Goodnough L T, Monk T.
Where does preoperative erythropoietin therapy count? A mathematical perspective.
Transfusion.
1999;
39(4)
392-395
- 14
Chun T Y, Martin S, Lepor H.
Preoperative recombinant human erythropoietin injection versus preoperative autologous
blood donation in patients undergoing radical retropubic prostatectomy.
Urology.
1997;
50(5)
727-732
- 15
Stowell Ch P, Chandler H, Jove M, Guilfoyle M, Wacholtz M C.
An Open-Label, Randomized Study to Compare the Safety and Efficacy of Perioperative
Epoetin alfa with preoperative autologous blood donation in total joint arthroplasty.
Orthopedics.
1999;
22, Supplement
105-112
Dr. med. H. Gombotz
Universitätsklinik für Anästhesiologie
Auenbruggerplatz 29
8036 Graz
Österreich
